Kingsview Wealth Management »

Oncolytics Biotech shares owned by Kingsview Wealth Management

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Kingsview Wealth Management from 13F filings

Historical chart of Kingsview Wealth Management investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Kingsview Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Kingsview Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.8k 11k 0.87
2025-09-30 $16k 11k 1.40
2025-06-30 $8.7k 11k 0.77
2025-03-31 $6.2k 11k 0.55
2024-12-31 $11k 12k 0.91
2024-09-30 $9.6k 11k 0.87
2024-06-30 $11k 11k 0.99
2024-03-31 $12k 11k 1.06
2023-12-31 $15k 11k 1.35

More positions owned by Kingsview Wealth Management

Northern Lts Fd Tr Iv Monarch Procap I (MPRO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYG)
Northern Lts Fd Tr Iv Monarch Ambassad (MAMB)
Ishares Tr Core Us Aggbd Et (AGG)
Northern Lts Fd Tr Iv Monarch Blue Ch (MBCC)
Northern Lts Fd Tr Iv Monarch Vol Fact (MVFG)
Northern Lts Fd Tr Iv Monarch Sel Subs (MSSS)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (SPTI)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Northern Lts Fd Tr Iv Monarch Vol Fact (MVFD)
Eli Lilly & Co. (LLY)

View all positions for Kingsview Wealth Management

Top funds holding Oncolytics Biotech

Citadel Advisors
Marshall Wace
Seeds Investor
International Assets Investment Management
Goldman Sachs Group
Connective Capital Management
XTX Topco
Virtu Financial
Tocqueville Asset Management
CIBC World Markets
Franklin Resources
Royal Bank of Canada
Geode Capital Management
Atlantic Trust
Headinvest

View all funds holding Oncolytics Biotech